Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021366
Filing Date
2017-11-03
Accepted
2017-11-03 06:05:08
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q insy-10q_20170930.htm 10-Q 2333237
2 EX-10.1 insy-ex101_116.htm EX-10.1 126513
3 EX-31.1 insy-ex311_8.htm EX-31.1 9129
4 EX-31.2 insy-ex312_7.htm EX-31.2 9010
5 EX-32 insy-ex32_9.htm EX-32 9119
  Complete submission text file 0001564590-17-021366.txt   9166242

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT insy-20170930.xml EX-101.INS 2453315
7 XBRL TAXONOMY EXTENSION SCHEMA insy-20170930.xsd EX-101.SCH 42553
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20170930_cal.xml EX-101.CAL 53580
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20170930_def.xml EX-101.DEF 130610
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20170930_lab.xml EX-101.LAB 361115
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20170930_pre.xml EX-101.PRE 274854
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 171174562
SIC: 2834 Pharmaceutical Preparations